- Home
- A-Z Publications
- Current Neuropharmacology
- Previous Issues
- Volume 14, Issue 6, 2016
Current Neuropharmacology - Volume 14, Issue 6, 2016
Volume 14, Issue 6, 2016
-
-
Mitochondrial Dysfunction in Gliomas: Pharmacotherapeutic Potential of Natural Compounds
Authors: Lalita Guntuku, V.G.M. Naidu and Veera G. YerraGliomas are the most common primary brain tumors either benign or malignant originating from the glial tissue. Glioblastoma multiforme (GBM) is the most prevalent and aggressive form among all gliomas, associated with decimal prognosis due to it's high invasive nature. GBM is also characterized by high recurrence rate and apoptosis resistance features which make the therapeutic targeting very challenging. Mitoch Read More
-
-
-
Cognitive Impairment Associated with Parkinson’s Disease: Role of Mitochondria
Authors: Nihar R. Das and Shyam S. SharmaParkinson’s disease (PD) is a movement disorder and is associated with some of the intellectual disabilities like cognitive dysfunctions. PD associated cognitive dysfunctions have been proved well in both preclinical and clinical set ups. Like other neurodegenerative diseases, insults to mitochondria have a significant role in the pathobiology of PD associated dementia (PDD). Neurotoxins like MPTP, mutations of the mitochondrial gene Read More
-
-
-
Potential Therapeutic Benefits of Maintaining Mitochondrial Health in Peripheral Neuropathies
Authors: Aparna Areti, Veera Ganesh Yerra, Prashanth Komirishetty and Ashutosh KumarBackground: Peripheral neuropathies are a group of diseases characterized by malfunctioning of peripheral nervous system. Neuropathic pain, one of the core manifestations of peripheral neuropathy remains as the most severe disabling condition affecting the social and daily routine life of patients suffering from peripheral neuropathy. Method: The current review is aimed at unfolding the possible role of mitochondrial dysfu Read More
-
-
-
Mitochondrial Dysfunction in Depression
Authors: Yashika Bansal and Anurag KuhadBackground: Depression is the most debilitating neuropsychiatric disorder with significant impact on socio-occupational and well being of individual. The exact pathophysiology of depression is still enigmatic though various theories have been put forwarded. There are evidences showing that mitochondrial dysfunction in various brain regions is associated with depression. Recent findings have sparked renewed appreciation for Read More
-
-
-
Endothelin Receptors, Mitochondria and Neurogenesis in Cerebral Ischemia
By Anil GulatiBackground: Neurogenesis is most active during pre-natal development, however, it persists throughout the human lifespan. The putative role of mitochondria in neurogenesis and angiogenesis is gaining importance. Since, ETB receptor mediated neurogenesis and angiogenesis has been identified, the role of these receptors with relevance to mitochondrial functions is of interest. Methods: In addition to work from our labo Read More
-
-
-
Nutraceuticals against Neurodegeneration: A Mechanistic Insight
Authors: Vivekkumar P. Dadhania, Priyanka P. Trivedi, Ajit Vikram and Durga Nand TripathiThe mechanisms underlying neurodegenerative disorders are complex and multifactorial; however, accumulating evidences suggest few common shared pathways. These common pathways include mitochondrial dysfunction, intracellular Ca2+ overload, oxidative stress and inflammation. Often multiple pathways co-exist, and therefore limit the benefits of therapeutic interventions. Nutraceuticals have recently gained impo Read More
-
-
-
Neuroprotection by Estrogen and Progesterone in Traumatic Brain Injury and Spinal Cord Injury
Authors: Evgeni Brotfain, Shaun E. Gruenbaum, Matthew Boyko, Ruslan Kutz, Alexander Zlotnik and Moti KleinIn recent years there has been a growing body of clinical and laboratory evidence demonstrating the neuroprotective effects of estrogen and progesterone after traumatic brain injury (TBI) and spinal cord injury (SCI). In humans, women have been shown to have a lower incidence of morbidity and mortality after TBI compared with age-matched men. Similarly, numerous laboratory studies have demonstrated that est Read More
-
-
-
Role of Neuromodulation and Optogenetic Manipulation in Pain Treatment
Authors: Sufang Liu, Changsheng Li, Ying Xing, Yanqing Wang and Feng TaoNeuromodulation, including invasive and non-invasive stimulation, has been used to treat intractable chronic pain. However, the mechanisms by which neuromodulation produces antinociceptive effect still remain uncertain. Optogenetic manipulation, a recently developed novel approach, has already proven its value to clinicians by providing new insights into mechanisms of current clinical neuromodulation methods as well as Read More
-
Volumes & issues
-
Volume 23 (2025)
-
Volume 22 (2024)
-
Volume 21 (2023)
-
Volume 20 (2022)
-
Volume 19 (2021)
-
Volume 18 (2020)
-
Volume 17 (2019)
-
Volume 16 (2018)
-
Volume 15 (2017)
-
Volume 14 (2016)
-
Volume 13 (2015)
-
Volume 12 (2014)
-
Volume 11 (2013)
-
Volume 10 (2012)
-
Volume 9 (2011)
-
Volume 8 (2010)
-
Volume 7 (2009)
-
Volume 6 (2008)
-
Volume 5 (2007)
-
Volume 4 (2006)
-
Volume 3 (2005)
-
Volume 2 (2004)
-
Volume 1 (2003)
Most Read This Month
Article
content/journals/cn
Journal
10
5
false
en
